HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetes.

AbstractAIM:
To examine prescribing practices and predictors of glucose-lowering therapy within the first year following diagnosis of Type 2 diabetes mellitus in a clinical care setting.
METHODS:
We followed people enrolled in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort from outpatient hospital clinics and general practices throughout Denmark in 2010-2013. We used Poisson regression to compute age- and gender-adjusted risk ratios (RRs).
RESULTS:
Among 1158 new Type 2 diabetes mellitus patients, 302 (26%) did not receive glucose-lowering therapy within the first year, 723 (62%) received monotherapy [685 (95%) with metformin], and 133 (12%) received more than one drug. Predictors of receiving any vs. no therapy and combination vs. monotherapy were: age < 40 years [RR: 1.29 (95% CI: 1.16-1.44) and 3.60 (95% CI: 2.36-5.50)]; high Charlson Comorbidity Index [RRs: 1.20 (95% CI: 1.05-1.38) and 2.08 (95% CI: 1.16-3.72)]; central obesity [RRs: 1.23 (95% CI: 1.04-1.44) and 1.93 (95% CI: 0.76-4.94)]; fasting blood glucose of ≥ 7.5 mmol/l [RRs: 1.25 (95% CI: 1.10-1.42) and 1.94 (95% CI: 1.02-3.71)]; and HbA1c ≥ 59 mmol/mol (≥ 7.5%) [RR: 1.26 (95% CI: 1.20-1.32) and 2.86 (95% CI: 1.97-4.14)]. Weight gain ≥ 30 kg since age 20, lack of physical exercise and C-peptide of < 300 pmol/l also predicted therapy.
CONCLUSIONS:
Comorbidity, young age, central obesity and poor baseline glycaemic control are important predictors of therapy one year after Type 2 diabetes mellitus debut.
AuthorsA Mor, K Berencsi, E Svensson, J Rungby, J S Nielsen, S Friborg, I Brandslund, J S Christiansen, A Vaag, H Beck-Nielsen, H T Sørensen, R W Thomsen
JournalDiabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 32 Issue 12 Pg. 1546-54 (Dec 2015) ISSN: 1464-5491 [Electronic] England
PMID26032247 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Authors. Diabetic Medicine © 2015 Diabetes UK.
Chemical References
  • Hypoglycemic Agents
  • Metformin
Topics
  • Adult
  • Age Factors
  • Aged
  • Body Mass Index
  • Cohort Studies
  • Denmark
  • Diabetes Mellitus, Type 2 (blood, complications, drug therapy)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • General Practitioners
  • Hospitalists
  • Humans
  • Hyperglycemia (prevention & control)
  • Hypoglycemic Agents (therapeutic use)
  • Male
  • Metformin (therapeutic use)
  • Middle Aged
  • Obesity, Abdominal (complications)
  • Outpatient Clinics, Hospital
  • Practice Patterns, Physicians'
  • Prospective Studies
  • Registries

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: